Literature DB >> 7001150

Reversal of experimental acute hepatic failure in the rat.

L Makowka, R E Falk, L E Rotstein, J A Falk, N Nossal, B Langer, L M Blendis, M J Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7001150     DOI： 10.1016/0022-4804(80)90016-5

Source DB:  PubMed          Journal:  J Surg Res        ISSN： 0022-4804            Impact factor:   2.192


× No keyword cloud information.
  5 in total

1.  A dog model for acetaminophen-induced fulminant hepatic failure.

Authors:  A Francavilla; L Makowka; L Polimeno; M Barone; J Demetris; J Prelich; D H Van Thiel; T E Starzl
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

2.  A fulminant hepatic failure model in the rat: involvement of interleukin-1beta and tumor necrosis factor-alpha.

Authors:  M Shito; U J Balis; R G Tompkins; M L Yarmush; M Toner
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

3.  New method of hepatocyte transplantation and extracorporeal liver support.

Authors:  A A Demetriou; J Whiting; S M Levenson; N R Chowdhury; R Schechner; S Michalski; D Feldman; J R Chowdhury
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

4.  The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine.

Authors:  A Francavilla; A DiLeo; L Polimeno; J Gavaler; R Pellicci; S Todo; I Kam; J Prelich; L Makowka; T E Starzl
Journal:  Hepatology       Date:  1986 Nov-Dec       Impact factor: 17.425

Review 5.  Cell and tissue engineering for liver disease.

Authors:  Sangeeta N Bhatia; Gregory H Underhill; Kenneth S Zaret; Ira J Fox
Journal:  Sci Transl Med       Date:  2014-07-16       Impact factor: 17.956
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.